HIGHLIGHTS
- who: Prostate cancer and collaborators from the Department of Biomedical and Clinical Sciences have published the Article: Activity and safety of KEES - an oral multi-drug chemo-hormonal combination regimen in metastatic castration-resistant, in the Journal: (JOURNAL) of September/30,/2022
- what: This study investigates the efficacy and safety of an oral chemo-hormonal regimen including and prednisolone (KEES) administered in a consecutive biweekly schedule. The aim of this study was to investigate treatment efficacy, toxicity and prognostic factors in a large real-world cohort of mCRPC patients treated with KEES. Ethics This study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.